Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.4869
-0.0290 (-5.62%)
At close: Sep 11, 2026, 4:00 PM EDT
0.4706
-0.0163 (-3.35%)
Pre-market: Sep 14, 2026, 7:17 AM EDT
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $9.47 million as of September 11, 2026. Its market cap has increased by 49.13% in one year.
Market Cap
9.47M
Enterprise Value
8.99M
1-Year Change
49.13%
Ranking
Category
Stock Price
$0.49
ChartMarket Cap Chart
Since February 26, 2018, Ensysce Biosciences's market cap has decreased from $59.64B to $9.47M, a decrease of -99.98%. That is a compound annual growth rate of -64.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 9.47M | 183.49% |
| Dec 31, 2025 | 3.34M | -68.54% |
| Dec 31, 2024 | 10.62M | 218.52% |
| Dec 29, 2023 | 3.33M | -30.67% |
| Dec 30, 2022 | 4.81M | -95.78% |
| Dec 31, 2021 | 113.99M | -99.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 10.72M |
| IN8bio | 10.55M |
| Vistagen Therapeutics | 10.52M |
| CytoMed Therapeutics | 9.92M |
| Aprea Therapeutics | 9.74M |
| Senti Biosciences Holdings | 9.53M |
| Exicure | 9.16M |
| Xenetic Biosciences | 9.14M |